Other research posts Life sciences 8 days left

Immunological Characterization of Patients with Idiopathic Inflammatory Myopathies: Anti-CCAR1 Antibodies in Patients With and Without Malignancy and Their Association with Anti-TIF1γ Antibodies

Università degli studi di Brescia, Italy

What the advert says

Idiopathic inflammatory myopathies (IIM) are rare autoimmune disorders in which malignancy represents a major cause of morbidity and mortality, particularly in cancer-associated myositis (CAM). Up to 25% of patients with IIM are diagnosed with cancer within three years before or after myositis onset...

Extract only. The full description, conditions and application form are on the original page.

The facts

LevelOther research posts
FieldMedical sciences
WhereUniversità degli studi di Brescia, Italy
FundingNot funded by a EU programme
Deadline26 November 2026
Listed viaEURAXESS (European Commission)
Open the original advert Applications are made on the institution's own page, never here.